T1	Participants 55 144	patients with head and neck cancer: a Hellenic Cooperative Oncology Group Phase III Study
T2	Participants 431 533	124 patients with histologically proven locally advanced non-nasopharyngeal head and neck cancer (HNC)
T3	Participants 1045 1063	groups A, B, and C
T4	Participants 1621 1655	patients with locally advanced HNC
